Inventor

Margaret Anne Brimble

Inventor

Auckland, NZ

Overview

2006–2021

Patent span

Human necessities

Primary field (CPC A)

Patents· 19 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Pprimary

A61PSpecific therapeutic activity of chemical compounds or medicinal preparations29%

A61KPreparations for medical, dental or toiletry purposes21%

C07KPeptides16%

C07DHeterocyclic compounds14%

C07CAcyclic or carbocyclic compounds7%

C12NMicroorganisms or enzymes5%

C07HSugars3%

G01NInvestigating or analysing materials by determining their chemical or physical properties3%

A01NPreservation of bodies of humans or animals or plants or parts thereof2%

PatentTitleYear

11,072,584Carbon monoxide releasing norbornenone compounds2021 11,014,960Amino acid and peptide conjugates and uses thereof2021 10,576,144Amino acid and peptide conjugates and conjugation process2020 10,494,344Carbon monoxide releasing norbornenone compounds2019 10,253,062Amino acid and peptide conjugates and uses thereof2019 9,650,418'Synthetic analogues of neural regeneration peptides'2017 9,198,420'Rodenticidal norbormide analogues'2015 8,637,567'Cognitive enhancement and cognitive therapy using glycyl-L-2-methylprolyl-L-glutamic acid'2014 8,519,127'Cyclic glycyl-2-allyl proline and its use in treatment of peripheral neuropathy'2013 8,309,684'Synthetic analogues of neural regeneration peptides'2012 8,138,304'Neural regeneration peptides and formulations thereof'2012 8,067,425'Neuroprotective bicyclic compounds and methods for their use'2011 8,013,170'Substituted pyrrolo[1,2-d][1,4]-diazonines and treatment of brain damage'2011 7,863,304'Analogs of glycyl-prolyl-glutamate'2011 7,776,876'Cyclic G-2Allylproline in treatment of Parkinson\'s disease'2010 7,714,020'Treatment of non-convulsive seizures in brain injury using G-2-methyl-prolyl glutamate'2010 7,605,177'Effects of glycyl-2 methyl prolyl glutamate on neurodegeneration'2009 7,485,630'Neuroprotective macrocyclic compounds and methods for their use'2009 7,041,314'GPE analogs and peptidominetics'2006

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2006–2014Patents assigned to NEUREN PHARMACEUTICALS LTD (9)· patent assignee history

2006–2021Based in Auckland, NZ· patent location history

2011–2020Patents assigned to BRIMBLE MARGARET ANNE (8)· patent assignee history

2011–2012Patents assigned to SIEG FRANK (3)· patent assignee history

2012–2017Patents assigned to CURONZ HOLDINGS COMPANY LTD (2)· patent assignee history

2020–2021Patents assigned to AUCKLAND UNISERVICES LTD (2)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees

Assignee	Patents	Span
NEUREN PHARMACEUTICALS LTD	9	2006–2014
BRIMBLE MARGARET ANNEself	8	2011–2020
SIEG FRANK	3	2011–2012
AUCKLAND UNISERVICES LTD	2	2020–2021
CURONZ HOLDINGS COMPANY LTD	2	2012–2017

Locations

Location	Patents	Span
Auckland, NZ	19	2006–2021